The role of magnetic resonance-guided laser ablation in neurooncology

References

• Maroon J, Onik G, Quigley MR, et al. Cryosurgery re-visited for the removal and destruction of brain, spinal and orbital tumours. Neurol Res 1992;14:294–302.
   PubMedGoogle Scholar
• Mia Y, Ni Y, Yu J, Zhang H, Marchal G. Evaluation of radiofrequency ablation as an alternative for the treatment of brain tumour in rabbits. J Neurooncol 2002;56:119–26.
   PubMedGoogle Scholar
• Britt R, Pounds DW, Lyons BE. Feasibility of treating malignant brain tumours with focused ultrasound. Prog Exp Tumour Res. 1984;28:232–45.
   PubMed Web of Science ®Google Scholar
• Winter A, Laing J, Paglione R, Sterzer F. Microwave hyperthermia for brain tumours. Neurosurgery 1985;17:387–99.
   PubMed Web of Science ®Google Scholar
• Jethwa P, Barrese JC, Gowda A, Shetty A, Danish SF. Magnetic resonance thermometry guided laser-induced thermal therapy for intracranial neoplasms: initial experience. Neurosurgery 2012;71:133–5.
   PubMed Web of Science ®Google Scholar
• Ascher P, Justich E, Schrottner O. A new surgical but less invasive treatment of central brain tumours: preliminary report. Acta Neurochir Suppl (Wien) 1991;52:78–80.
   PubMedGoogle Scholar
• Bettag M, Ulrich F, Schober R, et al. Stereotactic laser therapy in cerebral gliomas. Acta Neurochir Suppl (Wien) 1991;52:81–3.
   PubMedGoogle Scholar
• Kahn T, Bettag M, Ulrich F, et al. MRI-guided laser-induced interstitial thermotherapy of cerebral neoplasms. J Comput Assist Tomogr 1994;18:519–32.
   PubMed Web of Science ®Google Scholar
• Patel N, Jethwa PR, Barrese JC, Hargreaves EL, Danish SF. Volumetric trends associated with MRI-guided laser-induced thermal therapy (LITT) for intracranial tumours. Lasers Surg Med 2013;45:362–9.
   PubMed Web of Science ®Google Scholar
• McNichols R, Gowda A, Kangasniemi M, et al. MR thermometry-based feedback control of laser interstitial thermal therapy at 980 nm. Lasers Surg Med 2004;34:48–55.
   PubMed Web of Science ®Google Scholar
• Schwarzmaier H, Eickmeyer F, von Tempelhoff W, et al. MR-guided laser irradiation of recurrent glioblastomas. J Magn Reson Imaging 2005;22:799–803.
   PubMed Web of Science ®Google Scholar
• Vogl T, Naguib NN, Eichler K, et al. Volumetric evaluation of liver metastases after thermal ablation: Long-term results following MR-guided laser-induced thermotherapy. Radiology 2008;249:865–71.
   PubMed Web of Science ®Google Scholar
• van Esser S, Stapper G, van Diest PJ, et al. Ultrasound- guided laser-induced thermal therapy for small palpable invasive breast carcinomas: A feasibility study. Ann Surg Oncol 2009;16:2259–63.
   PubMed Web of Science ®Google Scholar
• Sercarz J, Bublik M, Joo J, et al. Outcomes of laser thermal therapy for recurrent head and neck cancer. Otolaryngol Head Neck Surg 2010;142:344–50.
   PubMedGoogle Scholar
• Vogl T, Lehnert T, Eichler K, et al. Adrenal metastases: CT-guided and MR-thermometry- controlled laser-induced interstitial thermotherapy. Eur Radiol 2007;17:2020–2027.
   PubMedGoogle Scholar
• Carpentier A, McNichols RJ, Stafford RJ, et al. Real-time magnetic resonance-guided laser thermal therapy for focal metastatic brain tumours. Neurosurgery 2008;6:21–8.
   Google Scholar
• Carpentier A, McNichols RJ, Stafford RJ, et al. Laser thermal therapy: real-time MRI-guided and computer-controlled procedures for metastatic brain tumours. Lasers Surg Med 2011;43:943–50.
   PubMed Web of Science ®Google Scholar
• Carpentier A, Chauvet D, Reina V, et al. MR-guided laser-induced thermal therapy (LITT) for recurrent glioblastomas. Lasers Surg Med 2012;44:361–8.
   PubMed Web of Science ®Google Scholar
• Schwarzmaier H, Eickmeyer F, von Tempelhoff W, et al. MR-guided laser-induced interstitial thermotherapy of recurrent glioblastoma multiforme: Preliminary results in 16 patients. Eur J Radiol 2006;59:208–15.
   PubMed Web of Science ®Google Scholar
• Mohammadi A, Hawasli AH, Rodriguez A, et al. The role of laser interstitial thermal therapy in enhancing progression-free survival of difficult-to-access high-grade gliomas: a multicenter study. Cancer Med 2014. doi:10.1002/cam4.266. [Epub ahead of print].
   PubMedGoogle Scholar
• Sloan A, Ahluwalia MS, Valerio-Pascua J, et al. Results of the NeuroBlate System first-in-humans Phase I clinical trial for recurrent glioblastoma: clinical article. J Neurosurg. 2013;118:1202–19.
   PubMed Web of Science ®Google Scholar
• Rao M, Hargreaves EL, Khan AJ, Haffty BG, Danish SF. Magnetic resonance-guided laser ablation improves local control for postradiosurgery recurrence and/or radiation necrosis. Neurosurgery 2014;74:658–67.
   PubMed Web of Science ®Google Scholar
• Jethwa P, Lee JH, Assina R, Keller IA, Danish SF. Treatment of a supratentorial primitive neuroectodermal tumour using magnetic resonance-guided laser-induced thermal therapy. J Neurosurg Paediatr 2011;8:468–75.
   PubMed Web of Science ®Google Scholar
• Vadivelu S, Schulder M. MRI-guided interstitial laser therapy of brain tumours intraoperative imaging and image-guided therapy. In: Jolesz FA, ed. Intraoperative Imaging and Image-Guided Therapy. Springer Science + Business Media:New York, NY. 2014:575–580.
   Google Scholar
• Roci E, Cakani B, Brace G, et al. Platinum-based chemotherapy in recurrent high-grade glioma patients: retrospective study. Med Arch 2014;68:140–3.
   PubMedGoogle Scholar
• Lamborn K, Chang SM, Prados MD. Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis. Neuro Oncol 2004;6:227.
   PubMed Web of Science ®Google Scholar
• Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005;352:987–96.
   PubMed Web of Science ®Google Scholar
• Scott J, Bauchet L, Fraum TJ, et al. Recursive partitioning analysis of prognostic factors for glioblastoma patients aged 70 years or older. Cancer 2012;118:5595–600.
   PubMed Web of Science ®Google Scholar
• Quigley M, Maroon JC. The relationship between survival and the extent of the resection in patients with supratentorial malignant gliomas. Neurosurgery 1991;29:385.
   PubMed Web of Science ®Google Scholar
• Laws E, Parney IF, Huang W, et al.; Glioma Outcomes Investigators. Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project. J Neurosurg 2003;99:467.
   PubMed Web of Science ®Google Scholar
• Oh S, Jee TK, Kong DS, et al. Outcome of conventional treatment and prognostic factor in elderly glioblastoma patients. Acta Neurochir (Wien) 2014;156:641–51.
   PubMedGoogle Scholar
• Liang H, Wang CW, Tseng HM, et al. Preoperative Prognostic Neurologic Index for Glioblastoma Patients Receiving Tumour Resection. Ann Surg Oncol 2014. [Epub ahead of print].
   Google Scholar
• Archavlis E, Tselis N, Birn G, et al. Survival analysis of HDR brachytherapy versus reoperation versus temozolomide alone: a retrospective cohort analysis of recurrent glioblastoma multiforme. BMJ Open 2013;3
   Google Scholar
• Taal W, Oosterkamp HM, Walenkamp AM, et al. Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial. Lancet Oncol 2014;S1470–2045:70314–6.
   Google Scholar
• Chen C, Huang R, MacLean A, et al. Recurrent high-grade glioma treated with bevacizumab: prognostic value of MGMT methylation, EGFR status and pretreatment MRI in determining response and survival. J Neurooncol 2013;115:267–76.
   PubMed Web of Science ®Google Scholar
• Luther NKD, Kano H, Mousavi SH, et al. Predicting tumour control after resection bed radiosurgery of brain metastases. Neurosurgery 2013;73:1001–6.
   PubMedGoogle Scholar
• Peterson H, Larson EW, Fairbanks RK, et al. Gamma knife treatment of brainstem metastases. Int J Mol Sci. 2014;15:9748–61.
   PubMed Web of Science ®Google Scholar
• Minniti G, Esposito V, Clarke E, et al.Fractionated stereotactic radiosurgery for patients with skull base metastases from systemic cancer involving the anterior visual pathway. Radiat Oncol 2014;9:110.
   PubMedGoogle Scholar
• Smith T, Lall RR, Lall RR, et al. Survival after surgery and stereotactic radiosurgery for patients with multiple intracranial metastases: results of a single-center retrospective study. J Neurosurg 2014;1–7 [Epub ahead of print].
   Google Scholar
• Patchell R, Tibbs PA, Regine WF, et al. (1989) Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 1989;1485–1489.
   Google Scholar
• Torres-Reveron J, Tomasiewicz HC, Shetty A, Amankulor NM, Chiang VL. Stereotactic laser induced thermotherapy (LITT): a novel treatment for brain lesions regrowing after radiosurgery. J Neurooncol 2013;113:495–503.
   PubMed Web of Science ®Google Scholar
• Jo K, Im YH, Kong DS, et al. Gamma knife radiosurgery for brain metastases from breast cancer. J Korean Neurosurg Soc 2013;54:399–404.
   PubMedGoogle Scholar
• Marvaso G, Barone A, Vaccaro C, et al.Repeat stereotactic radiosurgery in the management of brain metastases from NSCLC: a case report and review of the literature. Oncol Lett 2013;6:897–900.
   PubMedGoogle Scholar
• Parlak CMH, Güler OC, Onal C, Topkan E. Definitive chemoradiation therapy following surgical resection or radiosurgery plus whole-brain radiation therapy in non-small cell lung cancer patients with synchronous solitary brain metastasis: a curative approach. Int J Radiat Oncol Biol Phys 2014;88:885–91.
   PubMed Web of Science ®Google Scholar
• Sawaya R, Hammoud M, Schoppa D, et al. Neurosurgical outcomes in a modern series of 400 craniotomies for treatment of parenchymal tumours. Neurosurgery 1998;42:1044–55.
   PubMed Web of Science ®Google Scholar
• Fabiano A, Alberico RA. Laser-interstitial thermal therapy for refractory cerebral oedema from post-radiosurgery metastasis. World Neurosurg 2014. doi:10.1016/j.wneu.2013.10.034. 81:3/4:652.e1–652.e4.
   Google Scholar